Advertisement

Muscle Gene Therapy

  • Dongsheng Duan
  • Jerry R. Mendell

Table of contents

  1. Front Matter
    Pages i-xvi
  2. Foundations for Muscle Gene Therapy

    1. Front Matter
      Pages 1-1
    2. Paul M. L. Janssen, Jonathan P. Davis
      Pages 3-12
    3. Ning Liu, Rhonda Bassel-Duby
      Pages 13-39
    4. Stephanie M. Shrader, Roberta Wrighten, Bruce F. Smith
      Pages 41-63
    5. Thierry VandenDriessche, Yoke Chin Chai, Dimitri Boon, Marinee K. Chuah
      Pages 81-97
    6. Alessio Rotini, Giorgia Giacomazzi, Ester Sara Di Filippo, Maurilio Sampaolesi
      Pages 99-119
    7. Jenna M. Kastenschmidt, Ali H. Mannaa, Karissa J. Muñoz, S. Armando Villalta
      Pages 121-139
    8. Yi Lai, Dongsheng Duan
      Pages 141-156
    9. Dan Wang, Alexander Brown, Guangping Gao
      Pages 179-192
    10. Michael E. Nance, Dongsheng Duan
      Pages 193-206
    11. Michael W. Lawlor, Joel S. Schneider, Martin K. Childers, Kristy J. Brown
      Pages 207-226
    12. Yetrib Hathout, Kristy J. Brown, Kanneboyina Nagaraju, Eric P. Hoffman
      Pages 239-252
    13. Alan O’Brien, Ronald D. Cohn
      Pages 275-287
  3. Preclinical Muscle Gene Therapy

    1. Front Matter
      Pages 289-289
    2. Katrin Hollinger, Julie M. Crudele, Jeffrey S. Chamberlain
      Pages 327-337
    3. Rachid Benchaouir, Aurelie Goyenvalle
      Pages 355-370
    4. Christopher E. Nelson, Charles A. Gersbach
      Pages 383-403
    5. Satvik Mareedu, Shalini Dwivedi, Nandita Niranjan, Gopal J. Babu
      Pages 405-415
    6. Cyrille Vaillend, Faouzi Zarrouki, Ophélie Vacca
      Pages 417-438
    7. William Lostal, Isabelle Richard
      Pages 439-451
    8. Charles H. Vannoy, Anthony Blaeser, Qi L. Lu
      Pages 469-490
    9. Marinee Chuah, Yoke Chin Chai, Sumitava Dastidar, Thierry VandenDriessche
      Pages 525-548
    10. Alberto Malerba, Fanny Roth, Vanessa Strings, Pradeep Harish, David Suhy, Capucine Trollet et al.
      Pages 549-564
    11. Jean-Baptiste Dupont, Michael W. Lawlor, Martin K. Childers
      Pages 565-577
    12. Stephanie Salabarria, Barry J. Byrne, Cristina Liberati, Manuela Corti
      Pages 579-596
    13. Kleopas A. Kleopa, Alexia Kagiava, Irene Sargiannidou
      Pages 621-644
    14. Axel Rossi, Hildegard Büning
      Pages 645-659
  4. Clinical Muscle Gene Therapy

    1. Front Matter
      Pages 661-661
    2. Jorge Quiroz, Kathryn Wagner
      Pages 667-680
    3. Dirk Fischer, Ulrike Bonati, Mike P. Wattjes
      Pages 699-708
    4. Jerry R. Mendell, Louise R. Rodino-Klapac, Christopher Walker
      Pages 709-725
    5. Jerry R. Mendell, Zarife Sahenk, Louise R. Rodino-Klapac
      Pages 727-743
    6. Svitlana Pasteuning-Vuhman, Annemieke Aartsma-Rus
      Pages 745-758
    7. Cristina Liberati, Stephanie Salabarria, Manuela Corti, Barry J. Byrne
      Pages 759-774
    8. Alisha M. Gruntman, Terence R. Flotte
      Pages 775-786
  5. Back Matter
    Pages 787-811

About this book

Introduction

About 7 million people worldwide are suffering from various inherited neuromuscular diseases.  Gene therapy brings the hope of treating these diseases at their genetic roots.  Muscle Gene Therapy is the only book dedicated to this topic. The first edition was published in 2010 when the field was just about to enter its prime time.  The progress made since then has been unprecedented.  The number of diseases that have been targeted by gene therapy has increased tremendously.  The gene therapy toolbox is expanded greatly with many creative novel strategies (such as genome editing and therapy with disease-modifying genes).  Most importantly, clinical benefits have begun to emerge in human patients.  To reflect rapid advances in the field, we have compiled the second edition of Muscle Gene Therapy with contributions from experts that have conducted gene therapy studies either in animal models and/or in human patients.  The new edition offers a much needed, up-to-date overview and perspective on the foundation and current status of neuromuscular disease gene therapy.  It provides a framework to the development and regulatory approval of muscle gene therapy drugs in the upcoming years.  This book is a must-have for anyone who is interested in neuromuscular disease gene therapy including those in the research arena (established investigators and trainees in the fields of clinical practice, veterinary medicine and basic biomedical sciences), funding and regulatory agencies, and patient community.


Keywords

clinical trial development diseases gene gene therapy gene transfer genes muscle vaccine

Editors and affiliations

  • Dongsheng Duan
    • 1
  • Jerry R. Mendell
    • 2
  1. 1.Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, MO, USA; Department of Neurology, School of Medicine, University of Missouri, Columbia, MO, USADepartment of Biomedical Sciences College of Veterinary Medicine, University of Missouri, Columbia, MO, USA; Department of Bioengineering, University of MissouriColumbiaUSA
  2. 2.Department of Pediatrics Nationwide Children’s Hospital and Research Institute, Department of Neurology Nationwide Children’s Hospital and Research InstituteThe Ohio State UniversityColumbusUSA

Bibliographic information

Industry Sectors
Pharma
Biotechnology